mutations and complex kar yotype. It follows a linear evolution through the CLL clone from the recurrent acquisition of CDKN2AGenetic susceptibility mechanisms. Most susceptibility loci map to non-coding regions with the genome, are primarily situated in active promoters or enhancers, and modify the binding web-sites of several transcription factor